Article

Mutations in Rv2983 as a novel determinant of resistance to nitroimidazole drugs in <i>Mycobacterium tuberculosis</i>

2018-10-31

Abstract excerpt

Delamanid represents one of two novel antimicrobial classes approved to treat tuberculosis in over 40 years. Pretomanid is another promising nitroimidazole pro-drug in clinical development. Characterization of the full spectrum of mutations conferring resistance to nitroimidazoles and their related phenotypes in Mycobacterium tuberculosis will inform development of suitable genotypic and phenotypic drug susceptib...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4c24e939-0405-5235-bc36-dcc40279cfcb
DOI: 10.1101/457754

Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest

Mutations in Rv2983 as a novel determinant of resistance to nitroimidazole drugs in <i>Mycobacterium tuberculosis</i>DOI 10.1101/457754Read

Mutations in <i>fbiD (Rv2983)</i> as a novel determinant of resistance to pretomanid and delamanid in <i>Mycobacterium tuberculosis</i>Semantic proximity Read

Mutations in fbiD (Rv2983) as a Novel Determinant of Resistance to Pretomanid and Delamanid in Mycobacterium tuberculosis.Semantic proximity Read

The evolution of nitroimidazole antibiotic resistance in <i>Mycobacterium tuberculosis</i>Semantic proximity Read

Predicting nitroimidazole antibiotic resistance mutations in Mycobacterium tuberculosis with protein engineering.Semantic proximity Read

Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis.Semantic proximity Read

Mutations in genes for the F420 biosynthetic pathway and a nitroreductase enzyme are the primary resistance determinants in spontaneous in vitro-selected PA-824-resistant mutants of Mycobacterium tuberculosis.Semantic proximity Read

Delamanid Resistance: Update and Clinical ManagementSemantic proximity Read

REBASTINIB, OLVEREMBATINIB, AND NAS-181 INHIBIT <i>MYCOBACTERIUM ABSCESSUS</i> BY DISRUPTING MYCOTHIOL HOMEOSTASISSemantic proximity Read

Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid.Semantic proximity Read

Pretomanid resistance: An update on emergence, mechanisms and relevance for clinical practiceSemantic proximity Read

Nitroimidazopyrazinones with oral activity against tuberculosis and Chagas disease in mouse models of infectionSemantic proximity Read

Natural Polymorphisms in <i>Mycobacterium tuberculosis</i> Conferring Resistance to Delamanid in Drug-naïve PatientsSemantic proximity Read